Cargando…

Compatibility study of rosmarinic acid with excipients used in pharmaceutical solid dosage forms using thermal and non-thermal techniques

Rosmarinic acid (RA) is a phenolic compound that presents well-documented anti-inflammatory, antioxidant and antitumor activities, and based on its pharmacological potential and poor bioavailability, several solid dosage forms have been developed to RA delivery. Therefore, in literature, there are n...

Descripción completa

Detalles Bibliográficos
Autores principales: Veras, Kleyton Santos, Fachel, Flávia Nathiely Silveira, Pittol, Vanessa, Garcia, Keth Ribeiro, Bassani, Valquíria Linck, dos Santos, Venina, Henriques, Amélia Teresinha, Teixeira, Helder Ferreira, Koester, Letícia Scherer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921175/
https://www.ncbi.nlm.nih.gov/pubmed/31885473
http://dx.doi.org/10.1016/j.jsps.2019.09.010
_version_ 1783481102297464832
author Veras, Kleyton Santos
Fachel, Flávia Nathiely Silveira
Pittol, Vanessa
Garcia, Keth Ribeiro
Bassani, Valquíria Linck
dos Santos, Venina
Henriques, Amélia Teresinha
Teixeira, Helder Ferreira
Koester, Letícia Scherer
author_facet Veras, Kleyton Santos
Fachel, Flávia Nathiely Silveira
Pittol, Vanessa
Garcia, Keth Ribeiro
Bassani, Valquíria Linck
dos Santos, Venina
Henriques, Amélia Teresinha
Teixeira, Helder Ferreira
Koester, Letícia Scherer
author_sort Veras, Kleyton Santos
collection PubMed
description Rosmarinic acid (RA) is a phenolic compound that presents well-documented anti-inflammatory, antioxidant and antitumor activities, and based on its pharmacological potential and poor bioavailability, several solid dosage forms have been developed to RA delivery. Therefore, in literature, there are no reports about RA compatibility with excipients. In this regard, the aim of the present study was to evaluate, for the first time, the compatibility of RA with excipients commonly used in solid dosage forms at a 1:1 (RA:excipient) ratio using differential scanning calorimetry (DSC), thermogravimetry (TG), Fourier-transform infrared (FTIR), solid-state nuclear magnetic resonance (ssNMR), and isothermal stress testing (IST) coupled with liquid chromatography (LC). The excipients selected were hydroxypropyl methylcellulose (HPMC), microcrystalline cellulose (MCC), lactose monohydrate (LAC), polyvinylpyrrolidone (PVP), talc (TALC), croscarmellose sodium (CCS), and magnesium stearate (MgSTE). According to DSC results, physical interactions were found between RA and HPMC, LAC, CCS, and MgSTE. The TG analyses confirmed the physical interactions and suggested chemical incompatibility. FTIR revealed physical interaction of RA with TALC and MgSTE and the ssNMR confirmed the physical interaction showed by FTIR and excluded the presence of chemical incompatibility. By IST, the greatest loss of RA content was found to CCS and MgSTE (>15%), demonstrating chemical incompatibilities with RA. High temperatures used in DSC and TG analyses could be responsible for incompatibilities in binary mixtures (BMs) with HPMC and LAC, while temperature above 25 °C and presence of water were factors that promote incompatibilities in BMs with CCS and MgSTE. Overall results demonstrate that RA was compatible with MCC and PVP.
format Online
Article
Text
id pubmed-6921175
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69211752019-12-27 Compatibility study of rosmarinic acid with excipients used in pharmaceutical solid dosage forms using thermal and non-thermal techniques Veras, Kleyton Santos Fachel, Flávia Nathiely Silveira Pittol, Vanessa Garcia, Keth Ribeiro Bassani, Valquíria Linck dos Santos, Venina Henriques, Amélia Teresinha Teixeira, Helder Ferreira Koester, Letícia Scherer Saudi Pharm J Original Article Rosmarinic acid (RA) is a phenolic compound that presents well-documented anti-inflammatory, antioxidant and antitumor activities, and based on its pharmacological potential and poor bioavailability, several solid dosage forms have been developed to RA delivery. Therefore, in literature, there are no reports about RA compatibility with excipients. In this regard, the aim of the present study was to evaluate, for the first time, the compatibility of RA with excipients commonly used in solid dosage forms at a 1:1 (RA:excipient) ratio using differential scanning calorimetry (DSC), thermogravimetry (TG), Fourier-transform infrared (FTIR), solid-state nuclear magnetic resonance (ssNMR), and isothermal stress testing (IST) coupled with liquid chromatography (LC). The excipients selected were hydroxypropyl methylcellulose (HPMC), microcrystalline cellulose (MCC), lactose monohydrate (LAC), polyvinylpyrrolidone (PVP), talc (TALC), croscarmellose sodium (CCS), and magnesium stearate (MgSTE). According to DSC results, physical interactions were found between RA and HPMC, LAC, CCS, and MgSTE. The TG analyses confirmed the physical interactions and suggested chemical incompatibility. FTIR revealed physical interaction of RA with TALC and MgSTE and the ssNMR confirmed the physical interaction showed by FTIR and excluded the presence of chemical incompatibility. By IST, the greatest loss of RA content was found to CCS and MgSTE (>15%), demonstrating chemical incompatibilities with RA. High temperatures used in DSC and TG analyses could be responsible for incompatibilities in binary mixtures (BMs) with HPMC and LAC, while temperature above 25 °C and presence of water were factors that promote incompatibilities in BMs with CCS and MgSTE. Overall results demonstrate that RA was compatible with MCC and PVP. Elsevier 2019-12 2019-09-25 /pmc/articles/PMC6921175/ /pubmed/31885473 http://dx.doi.org/10.1016/j.jsps.2019.09.010 Text en © 2019 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Veras, Kleyton Santos
Fachel, Flávia Nathiely Silveira
Pittol, Vanessa
Garcia, Keth Ribeiro
Bassani, Valquíria Linck
dos Santos, Venina
Henriques, Amélia Teresinha
Teixeira, Helder Ferreira
Koester, Letícia Scherer
Compatibility study of rosmarinic acid with excipients used in pharmaceutical solid dosage forms using thermal and non-thermal techniques
title Compatibility study of rosmarinic acid with excipients used in pharmaceutical solid dosage forms using thermal and non-thermal techniques
title_full Compatibility study of rosmarinic acid with excipients used in pharmaceutical solid dosage forms using thermal and non-thermal techniques
title_fullStr Compatibility study of rosmarinic acid with excipients used in pharmaceutical solid dosage forms using thermal and non-thermal techniques
title_full_unstemmed Compatibility study of rosmarinic acid with excipients used in pharmaceutical solid dosage forms using thermal and non-thermal techniques
title_short Compatibility study of rosmarinic acid with excipients used in pharmaceutical solid dosage forms using thermal and non-thermal techniques
title_sort compatibility study of rosmarinic acid with excipients used in pharmaceutical solid dosage forms using thermal and non-thermal techniques
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921175/
https://www.ncbi.nlm.nih.gov/pubmed/31885473
http://dx.doi.org/10.1016/j.jsps.2019.09.010
work_keys_str_mv AT veraskleytonsantos compatibilitystudyofrosmarinicacidwithexcipientsusedinpharmaceuticalsoliddosageformsusingthermalandnonthermaltechniques
AT fachelflavianathielysilveira compatibilitystudyofrosmarinicacidwithexcipientsusedinpharmaceuticalsoliddosageformsusingthermalandnonthermaltechniques
AT pittolvanessa compatibilitystudyofrosmarinicacidwithexcipientsusedinpharmaceuticalsoliddosageformsusingthermalandnonthermaltechniques
AT garciakethribeiro compatibilitystudyofrosmarinicacidwithexcipientsusedinpharmaceuticalsoliddosageformsusingthermalandnonthermaltechniques
AT bassanivalquirialinck compatibilitystudyofrosmarinicacidwithexcipientsusedinpharmaceuticalsoliddosageformsusingthermalandnonthermaltechniques
AT dossantosvenina compatibilitystudyofrosmarinicacidwithexcipientsusedinpharmaceuticalsoliddosageformsusingthermalandnonthermaltechniques
AT henriquesameliateresinha compatibilitystudyofrosmarinicacidwithexcipientsusedinpharmaceuticalsoliddosageformsusingthermalandnonthermaltechniques
AT teixeirahelderferreira compatibilitystudyofrosmarinicacidwithexcipientsusedinpharmaceuticalsoliddosageformsusingthermalandnonthermaltechniques
AT koesterleticiascherer compatibilitystudyofrosmarinicacidwithexcipientsusedinpharmaceuticalsoliddosageformsusingthermalandnonthermaltechniques